Physician profile
Joann Marie St Pierre
NPI 1922173053
$15,174.97
in general payments reported to CMS, 2019-2025
37 companies · $8,401 in 2025
The $8,401 reported for 2025 was more than what 99% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,990 · 2022: $958 · 2023: $1,294 · 2024: $1,532 · 2025: $8,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,000 · Food and Beverage: $4,973 · Consulting Fee: $675 · Travel and Lodging: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,000.00 |
| Food and Beverage | $4,973.42 |
| Consulting Fee | $675.00 |
| Travel and Lodging | $579.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $6,300.61 | 2023-2025 | Symbravo, Sunosi |
| Allergan, INC. | $2,634.95 | 2021 | |
| Abbvie INC. | $1,570.98 | 2021-2025 | |
| Pfizer INC. | $1,103.34 | 2023-2025 | |
| Ucb, INC. | $357.84 | 2023-2025 | Briviact, Nayzilam, Zilbrysq |
| Novartis Pharmaceuticals Corporation | $353.40 | 2024-2025 | |
| Lilly USA, LLC | $340.57 | 2021-2025 | Kisunla, Amyvid, Emgality |
| Eisai INC. | $304.60 | 2023-2025 | |
| Csl Behring | $222.11 | 2021-2025 | Hizentra |
| Inspire Medical Systems, INC. | $207.35 | 2023-2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $193.79 | 2023-2024 | Hyqvia |
| Biohaven Pharmaceutical Holding Company Ltd. | $151.76 | 2022 | |
| Grifols USA, LLC | $144.81 | 2021-2025 | Gamunex-C |
| Genzyme Corporation | $136.35 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $135.10 | 2022-2024 | Ultomiris |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann St Pierre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.